{"id":3416,"date":"2013-12-12T16:11:45","date_gmt":"2013-12-12T16:11:45","guid":{"rendered":"\/?p=3416"},"modified":"2013-12-12T16:12:00","modified_gmt":"2013-12-12T16:12:00","slug":"biomatrix-scientific-group-inc-otcmktsbmsn-riles-investors-again-with-drug-test-results","status":"publish","type":"post","link":"\/articles\/biomatrix-scientific-group-inc-otcmktsbmsn-riles-investors-again-with-drug-test-results\/","title":{"rendered":"BioMatrix Scientific Group, Inc. (OTCMKTS:BMSN) Riles Investors Again with Drug Test Results"},"content":{"rendered":"

BioMatrix Scientific Group, Inc. (OTCMKTS:BMSN<\/a>) is still pressed down, but a piece of news caused buying to revive. BMSN<\/a> grew by more than 18% on Wednesday, reaching $0.0019 on buying volumes above $476,000. BMSN<\/a> enticed investors again with a PR message announcing success with animal model trials on one of its drug proposals, HemaXellerate I TM. \"BMSN1212.png\" <\/p>\n

Of course, an animal model is still quite far from ensuring earnings, or even allowing the drug to come to the market. Still, for BMSN<\/a> those are the highest buying volumes since the summer. The ticker is a long-defunct promotion, which turned into a double-zero bid, trading choppily despite snippets of positive news. This stock has long lost its direction, but has its days of separate strong earnings. \"BMSN1212.png\"<\/p>\n

Now, BMSN<\/a> opened up on Thursday with a bit of drama, starting the day upward and reversing the trend. But this is not unusual behavior- periodically, BMSN<\/a> spikes when volumes pick up, only to continue drifting on less active trading.<\/p>\n

BMSN<\/a> was abandoned by promoters at the end of September, and it has not been above the penny levels since the spring of this year. The ticker, without a promotion or publicity, has touched triple-zeroes easily in a sharp fall at the end of last year. Now, BMSN<\/a> is on a slow downward trend, but it takes more care of awareness with publicity and hopeful announcements on its innovative therapies.<\/p>\n

If you are looking for a more cheerful drug developer, Applied DNA Sciences, Inc. (OTCMKTS:APDN<\/a>) is trending right now, on a few days of solid buying and climbing. APDN<\/a> already reached 15 cents, adding a third to its price.<\/p>\n

Elite Pharmaceuticals, Inc. (OTCBB:ELTP<\/a>) started off as the different pharmaceutical bid, only to retreat and cause painful losses. So while BMSN<\/a> is a known risk factor, more hopeful companies never guarantee a good development.<\/p>\n

If you are still willing to try out BMSN<\/a>, keep in mind that this ticker is unpredictable, moving in opposing directions quite often, and easily wiping out the gains. Do not fall outright for the longer-term promises, and avoid investing sums that you cannot afford to lose on the inevitable corrections.<\/p>\n","protected":false},"excerpt":{"rendered":"

BioMatrix Scientific Group, Inc. (OTCMKTS:BMSN) is still pressed down, but a piece of news caused buying to revive. BMSN grew by more than 18% on Wednesday, reaching $0.0019 on buying volumes above $476,000. BMSN...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[572,167,797],"class_list":["post-3416","post","type-post","status-publish","format-standard","hentry","category-news","tag-apdn","tag-bmsn","tag-eltp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=3416"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3416\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=3416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=3416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=3416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}